How Screening plays role in Covid-19 management? Results of a Cross-Sectional Study on Covid-19 patients signs and symptoms

Abstract

Background and objective: Today, COVID-19 outbreak has become a global alert. So, lots of medical complications and socioeconomic and mental burdens have arisen following the outbreak of the disease. There is no adequate general strategy for total control of the virus’s widespread. According to this, preventive or early diagnostic measures are crucial. In this study, we designed a questionnaire in the context of the 4030 telephonic platform to assess the most common symptoms of COVID-19 in Iran. Materials and Methods: A questionnaire that had been designed with 20 common and rare symptoms of COVID-19 was filled out by 115 operators of 4030, a 24-hour call center to answer the Iranians' questions associated with COVID-19 and screen probable COVID-19 cases. Results: Common COVID-19 symptoms among people included cough, dyspnea, sore throat, myalgia, headache, anosmia, fever, dysgeusia, chilling, lethargy, and fatigue. Also, less common symptoms were rhinorrhea, sneeze, vomiting, diarrhea, nasal congestion, eyesore, stomach ache, jaw pain, dry mouth, and abdominal cramps. Discussion and Conclusion: Our study showed that the most common symptoms of COVID-19 in Iran include cough, dyspnea, sore throat, myalgia, headache, anosmia, fever, dysgeusia, chilling, lethargy, and fatigue. Some symptoms may incident due to over-use of disinfectants, or aggravated by fear of infection, or misdiagnosed with other issues such as food poisoning, flu, panic attacks, and allergies. Consequently, It seems that screening can help find new cases who haven’t refered to hospitals and health care centres, and this can result in COVID-19 improving, Covid-19 management, and decreasing the costs of patients and health systems.

Keywords

• COVID-19
• COVID-19; diagnosis strategy; screening; symptoms; call center.
• diagnosis strategy
• screening
• symptoms
• call center

References

1. Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, et al. Coronavirus disease 2019 (COVID-19): a perspective from China. Radiology. 2020;296(2):E15-E25.
2. Tavakoli Far F, Amiri-Ardekani E. SPIKE PROTEIN AND ITS PROTEASES ROLE IN SARS-COV-2 PATHOGENICITY AND TREATMENT; A REVIEW. Proceeding of the Shevchenko Scientific Society Medical Sciences. 2021;64(1).
3. Tuite AR, Bogoch, II, Sherbo R, Watts A, Fisman D, Khan K. Estimation of Coronavirus Disease 2019 (COVID-19) Burden and Potential for International Dissemination of Infection From Iran. Annals of internal medicine. 2020;172(10):699-701.
4. Worldometer. Reported Cases and Deaths by Country or Territory; Iran 2021 [June 17, 2021]. Available from: https://www.worldometers.info/coronavirus/country/iran/.
5. McArthur L, Sakthivel D, Ataide R, Chan F, Richards JS, Narh CA. Review of burden, clinical definitions, and management of COVID-19 cases. The American journal of tropical medicine and hygiene. 2020;103(2):625-38.
6. Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323(18):1775-6.
7. Yang X, Yu Y, Xu J, Shu H, Liu H, Wu Y, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-81.
8. Carfì A, Bernabei R, Landi F, Gemelli Against C-P-ACSG. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603-5.

9. Xiong W, Kwan P, Zhou D, Del Felice A, Duncan JS, Sander JW. Acute and late neurological complications of COVID19: the quest for evidence. Brain Res. 2020;143(12):e99-e.
10. Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med. 2020.
11. Jonker PK, Van der Plas WY, Steinkamp PJ, Poelstra R, Emous M, Van der Meij W, et al. Perioperative SARS-CoV-2 infections increase mortality, pulmonary complications, and thromboembolic events: a Dutch, multicenter, matched-cohort clinical study. Surgery. 2021;169(2):264-74.
12. Wang S, Kang B, Ma J, Zeng X, Xiao M, Guo J, et al. A deep learning algorithm using CT images to screen for Corona Virus Disease (COVID-19). European radiology. 2021:1-9.
13. Chowdhury ME, Rahman T, Khandakar A, Mazhar R, Kadir MA, Mahbub ZB, et al. Can AI help in screening viral and COVID-19 pneumonia? IEEE Access. 2020;8:132665-76.
14. call4030 [Internet] 2021 [cited 2021 May 17]. Available from: https://call4030.ir/fa/Pages/aboutus/234/3.
15. Organization WH. COVID-19 weekly epidemiological update, 25 May 2021 [Internet] 2021 [updated 25 May 2021; cited 2021 June 1]. 41:[Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---25-may-2021.
16. Kara Steel, Davies. B. Coronavirus (COVID-19) Infection Survey: characteristics of people testing positive for COVID-19 in England, 27 January 2021 [Internet] 2021 [cited 2021 May 21,]. 27 January 2021:[Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/characteristicsofpeopletestingpositiveforcovid19inengland27january2021.
17. Page ML. Indian COVID-19 variant (B.1.617) [Internet] 2021 [cited 2021 June, 7]. Available from: https://www.newscientist.com/definition/indian-covid-19-variant-b-1-617/.